177 related articles for article (PubMed ID: 11765476)
1. [Tumor necrosis factor alpha in chronic heart failure. Clinical manifestation and therapeutic possibilities].
Genth-Zotz S; Bolger AP; Anker SD
Herz; 2001 Nov; 26(7):437-46. PubMed ID: 11765476
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications.
Bolger AP; Anker SD
Drugs; 2000 Dec; 60(6):1245-57. PubMed ID: 11152010
[TBL] [Abstract][Full Text] [Related]
3. [Immunactivation in chronic heart failure. Inflammatory mediators].
Genth-Zotz S; von Haehling S; Blankenberg S
Z Kardiol; 2004; 93 Suppl 4():IV24-30. PubMed ID: 15085363
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of tumour necrosis factor-alpha antagonists in patients with chronic heart failure.
Javed Q; Murtaza I
Heart Lung Circ; 2013 May; 22(5):323-7. PubMed ID: 23337264
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications.
von Haehling S; Jankowska EA; Anker SD
Basic Res Cardiol; 2004 Jan; 99(1):18-28. PubMed ID: 14685702
[TBL] [Abstract][Full Text] [Related]
6. Immunological mechanisms of pentoxifylline in chronic heart failure.
Shaw SM; Shah MK; Williams SG; Fildes JE
Eur J Heart Fail; 2009 Feb; 11(2):113-8. PubMed ID: 19168508
[TBL] [Abstract][Full Text] [Related]
7. Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases.
Sinagra E; Perricone G; Romano C; Cottone M
Eur J Intern Med; 2013 Jul; 24(5):385-92. PubMed ID: 23333028
[TBL] [Abstract][Full Text] [Related]
8. [Importance of tumor necrosis factor-alpha in the pathogenesis of heart failure].
Heberto Herrera Garza E; Herrera Garza JL; Rodríguez González H; Treviño Treviño A; Ibarra Flores M; Torre Amione G
Rev Esp Cardiol; 2002 Jan; 55(1):61-6. PubMed ID: 11784525
[TBL] [Abstract][Full Text] [Related]
9. Role of tumour necrosis factor-alpha in the progression of heart failure: therapeutic implications.
Torre-Amione G; Vooletich MT; Farmer JA
Drugs; 2000 Apr; 59(4):745-51. PubMed ID: 10804032
[TBL] [Abstract][Full Text] [Related]
10. Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches.
Parissis JT; Fountoulaki K; Paraskevaidis I; Kremastinos D
Expert Opin Investig Drugs; 2005 May; 14(5):567-77. PubMed ID: 15926864
[TBL] [Abstract][Full Text] [Related]
11. Immune activation in chronic heart failure.
Torre-Amione G
Am J Cardiol; 2005 Jun; 95(11A):3C-8C; discussion 38C-40C. PubMed ID: 15925558
[TBL] [Abstract][Full Text] [Related]
12. Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links.
Jankowska EA; Ponikowski P; Piepoli MF; Banasiak W; Anker SD; Poole-Wilson PA
Cardiovasc Res; 2006 Jun; 70(3):434-45. PubMed ID: 16480965
[TBL] [Abstract][Full Text] [Related]
13. An inverse correlation between TNF alpha serum levels and heart rate variability in patients with heart failure.
Nikolic VN; Jevtovic-Stoimenov T; Stokanovic D; Milovanovic M; Velickovic-Radovanovic R; Pesic S; Stoiljkovic M; Pesic G; Ilic S; Deljanin-Ilic M; Marinkovic D; Stefanovic N; Jankovic SM
J Cardiol; 2013 Jul; 62(1):37-43. PubMed ID: 23611168
[TBL] [Abstract][Full Text] [Related]
14. Isoproterenol inhibits bacterial lipopolysaccharide-stimulated release of tumor necrosis factor-alpha from human heart tissue.
Smart KR; Warejcka DJ; Castresana MR; Dalton ML; Webb JG; Newman WH
Am Surg; 2000 Oct; 66(10):947-51. PubMed ID: 11261622
[TBL] [Abstract][Full Text] [Related]
15. Immune and neurohormonal pathways in chronic heart failure.
Sharma R; Anker SD
Congest Heart Fail; 2002; 8(1):23-8, 48. PubMed ID: 11821625
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease.
Sack M
Pharmacol Ther; 2002; 94(1-2):123-35. PubMed ID: 12191598
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure.
Gielen S; Adams V; Möbius-Winkler S; Linke A; Erbs S; Yu J; Kempf W; Schubert A; Schuler G; Hambrecht R
J Am Coll Cardiol; 2003 Sep; 42(5):861-8. PubMed ID: 12957433
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha, biologic agents and cardiovascular risk.
Sarzi-Puttini P; Atzeni F; Doria A; Iaccarino L; Turiel M
Lupus; 2005; 14(9):780-4. PubMed ID: 16218487
[TBL] [Abstract][Full Text] [Related]
19. Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
Kotyla PJ
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895751
[TBL] [Abstract][Full Text] [Related]
20. Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure.
Rumalla VK; Calvano SE; Spotnitz AJ; Krause TJ; Hilkert RJ; Lin E; Lowry SF
Ann Surg; 2002 Aug; 236(2):254-60. PubMed ID: 12170032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
